Diabetes(Oral Hypoglycemic Agents)

Composition : One tablet contains
Glimepiride - 2mg

Indication & Usage : noninsulin-dependent (Type II) diabetes mellitus (NIDDM)

• MEPIRIL is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate.
• Refer to insert-paper for further information.

Dosage & Administration :

• Dosage is determined by the results of blood and urinary glucose determinations.
• The starting dose is 1 mg glimepiride per day. If control is unsatisfactory the dosage should be increased, based on the glycaemic control, in a stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3 or 4 mg glimepiride per day.
• A dosage of more than 4mg glimepiride per day gives better results only in exceptional cases. The maximum recommended dose is 6mg glimepiride per day.

Package : 100, 500 Tablets

Composition : One tablet contains
Metformin.HCI - 500mg
Glibenclamide - 5/2.5mg

Indication & Usage :

• METIBEN is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone.
• METIBEN is indicated as second-line therapy when diet, exercise, and initial treatment with a sulfonylurea or metformin do not result in adequate glycemic control in patients with type 2 diabetes.

Dosage & Administration

• The recommended starting dose is 500/2.5 mg once a day with a meal.
• The maximum recommended daily dose is 2,000 mg metformin / 20 mg glyburide.

Package : 4ml/Amp x 5,20ml/Amp x 5

Composition : One tablet contains
Pioglitazone HCI - 200mg

Indication & Usage :
Treatment of type 2 diabetes mellitus inadequately controlled by diet

Dosage & Administration :

• Once daily with or without food
• Monotherapy : The recommended starting dosage is 15 mg once daily, if greater therapeutic effect is needed, to 30 mg once daily.

Package : 30 Tablets